Used as a potent inhibitor in pharmaceutical research, particularly in the development of kinase inhibitors for cancer therapy. Its structure enables selective targeting of specific signaling pathways involved in tumor growth and proliferation. Commonly employed in preclinical studies to evaluate antitumor activity, especially in models of solid tumors and hematologic malignancies. Also utilized as a chemical probe to study cellular mechanisms related to apoptosis and cell cycle regulation. Its trifluoromethyl and imidazole groups enhance metabolic stability and binding affinity, making it valuable in structure-activity relationship (SAR) studies for optimizing drug candidates.